Consistent with the above studies, we examined the expression of HMGCS1, ELOVL1, and GSTZ1 and found that they were considerably promoted, while that of LTA4H was relatively curbed in BC samples, in addition with the significant correlation between the expression level of 5 FMGs except for HMGCS1 and OS of BC patients. Here, ELOVL1 is linked to breast cancer.